Dedicated to Professor F. Ekkehardt Hahn on the occasion of his 65th birthday Heterobimetallic complexes bearing NHC donor ligands are gaining immense popularity in organometallic chemistry and tandem catalysis. It is known that the NHC reacts with Pd II in the presence of pyridine to yield PEPPSI type complexes and the NHC ligands having ortho-CÀ H proton easily orthometalate to Ir III or Rh III centers. Combining these two methodologies in a stepwise fashion, we present here a series of heterobimetallic Ir III À Pd II and Rh III À Pd II complexes from a dicarbene donor ligand featuring cyclometalated Ir III or Rh III and mixed NHC^Py/PPh 3 coordinated Pd II centers. All the heterobimetallic complexes have been structurally characterized by X-ray crystallographic analysis. The heterobimetallic complexes featuring mixed NHC^PPh 3 coordinated Pd II centers show better activity in tandem Suzuki-Miyaura/transfer hydrogenation reactions compared to both, the heterobimetallic complexes possessing PEPPSI type Pd II centers, and the equimolar mixture of their mononuclear Pd II and Rh III or Ir III counterparts. The heterobimetallic complex featuring cyclometalated Ir III and mixed NHC^PPh 3 coordinated Pd II center shows excellent selectivity for 4-biphenylmethanol (isolated yield: 92 %) in tandem catalysis.
Although a rare breast cancer subtype, SCCB is of considerable interest due to its pathological heterogeneity and differences in clinical behavior and less reported occurrence of nodal metastasis.
Considering the difficulty of clinical diagnosis of this tumour, strong suspicion is indicated when a patient presents with voluminous, well circumscribed renal lesions.
The Front Cover shows the combined action of two different metal centers in heterobimetallic MIII−PdII (M=Rh, Ir) complexes, featuring cyclometalated MIII and mixed NHC∧
Py/PPh3 coordinated PdII centers, during tandem Suzuki‐Miyaura/transfer hydrogenation reactions. The heterobimetallic complex, bearing cyclometalated IrIII and mixed NHC∧
PPh3 donor ligands at the PdII center, shows excellent selectivity for 4‐biphenylmethanol in the tandem reaction. More information can be found in the Full Paper by R. Maity and co‐workers.
The field of asymmetric catalysis is rapidly developing and the chiral ligands play a key role in enantioselective transition‐metal catalysis. The electron‐rich chiral N‐heterocyclic carbenes (NHCs) have established themselves as a popular class of stereodirecting ancillary ligands to catalyze enantioselective organic transformations in more efficient ways. Several novel transition‐metal complexes in combination with tailored ligand design have emerged during last few decades in asymmetric catalysis. The tailor‐made NHCs can easily be accessed due to the modular synthesis of their parent azolium salt precursors. Their donor capability and the molecular shape can easily be tuned by changing substituent at N‐atom or by changing the cyclic backbone framework. This review article aims to describe the recent advances in this rapidly evolving research area of enantioselective catalysis using well‐defined transition‐metal complexes possessing chiral NHC donor ligands.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.